Industry News
Predicting breast cancer metastatic risk
Jun 05, 2014
The study was led by researchers at the National Cancer Institute (NCI)-designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein... Read More
Promising long-term results for combination immunotherapy for advanced melanoma
Jun 05, 2014
The first long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results - long-lasting with high survival rates ... Read More
Public health often ignored in transportation policy: major roads built in poorest neighborhoods
Jun 05, 2014
A new study from the University of Colorado Denver shows public health issues are often ignored in many transportation projects, especially when major roads are built through lower-income... Read More
Engineered aptimer targets malignant and tumor-associated T cells
Jun 05, 2014
The transcription factor STAT3 mediates tumor survival, proliferation, invasion, and immunosuppression, and is persistently activated in tumor cells and tumor-associated immune cells. Read More
New path discovered to stop breast cancer cells from invading organs
Jun 05, 2014
The primary cause of death from breast cancer is the spread of tumor cells from the breast to other organs in the body. Read More
What is science doing to improve the health and lives of cancer survivors?
Jun 04, 2014
Following this week's National Cancer Survivors Day, we examine the latest research aimed at tackling health issues commonly experienced by cancer survivors. Read More
New insight into drug resistance in metastatic melanoma
Jun 04, 2014
A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment. Read More
Researchers deliver double dose of lung cancer discoveries
Jun 04, 2014
Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) are reporting exciting dual discoveries in the treatment of non-small-cell lung cancer (NSCLC), which accounts for about 85 percent... Read More
New study data find Avastin® (bevacizumab) and cetuximab help patients with KRAS wild-type advanced bowel cancer live similar length of time
Jun 04, 2014
CALGB 80405, a large, independent, phase III study, designed to assess the superiority in overall survival (OS) of cetuximab over Avastin® (bevacizumab) when combined with either FOLFOX or... Read More
Researchers use new simple cost effective technology to unravel cancer through standard imaging
Jun 04, 2014
Researchers at Maastricht University Medical Center+ (Maastricht UMC+) and the MAASTRO Clinic have developed a new medical imaging analysis method to predict the risk of dying of cancer in patients. Read More
Previous Page Next Page